Supplyside West

Booth 3543
 
TriNutra and its Korean partner, HuTri Corporation, have announced the completion of a new clinical study which concluded that Thymoquin, a patended black seed oil standardized to 3% thymoquinone with at least 1.2% p-Cymene and less than 1.25% free fatty acids, was linked to significant improvements in halitosis and sensitive teeth. The study, at press time, still awaits publication.
 
“We are thrilled to supply the first patent pending ThymoQuin oral health care product. ThymoQuin-OCare is a powerful, plant-based option for improved oral health. We have been working on this project for a while, analyzing several BSO [black seed oil] sources, and testing them in vitro compared to existing popular products. We found that the full-spectrum BSO, standardized thymoquinone level, higher ratio of thymoquinone to p-cymene (at least 3:1 ) and low free fatty acids, by far, improve oral health,” said Alex Chuyoun Song, CEO at HuTri Corporation.
 
“HuTri Corporation has been a great partner in spearheading the research behind ThymoQuin’s oral health capacity, which is now specially branded as ThymoQuin-OCare,” said Morris Zelkah, CEO at TriNutra. “We are excited about the opportunity ThymoQuin-Ocare presents in this category as it continues to demonstrate superior results.”
 
ThymoQuin-OCare’s oral health applications include but aren’t limited to mouthwash, toothpaste, and dietary supplements.